Five-year follow-up of active surveillance for prostate cancer: A Canadian community-based urological experience
The percentage of prostate cancer with low-risk characteristics has increased since the mid-1990s largely due to widespread prostate-specific antigen (PSA) screening. Over a similar period, the percentage of prostate cancer mortalities has reduced by more than 40%. There is now growing evidence that men with low-risk prostate cancer may not benefit from radical treatment. This has created controversy regarding PSA screening practices and the treatment of low-risk prostate cancer due to concerns of overdiagnosis and overtreatment. Active surveillance (AS) is an accepted alternative to immediate intervention for favourable-risk prostate cancer and it has shown promise in reducing overtreatment. Several large […]